Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.42 |
| ▸ | CTSV | O60911 | 3/20 | 0.41 |
| ▸ | CTSL | P07711 | 3/20 | 0.41 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.40 |
| ▸ | MYC | P01106 | 1/20 | 0.39 |
| ▸ | MAX | P61244 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7152813 | 0.94 | MEN1 (0.43) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL7154482 | 0.90 | KMT2A (0.42) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL7552860 | 0.84 | MEN1 (0.53) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL646471 | 0.82 | MEN1 (0.54) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL30061165 | 0.82 | MEN1 (0.54) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL27581338 | 0.82 | MEN1 (0.51) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL5462629 | 0.81 | MEN1 (0.46) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL7907625 | 0.80 | MEN1 (0.54) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL12734031 | 0.78 | MEN1 (0.50) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL5344847 | 0.78 | MEN1 (0.50) | MEN1KMT2ANPC1RAB9AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6531632-B2 | Reacting dihydroxy compound with halogenated o-nitrophenol | INFINEON TECHNOLOGIES AG (DE) | 2003-03-11 | — | — | US | disclosed |
| US-20020010370-A1 | Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same | POLARIS INNOVATIONS LIMITED (IE) | 2002-01-24 | — | — | US | disclosed |
| EP-1132374-A2 | Bis-o-aminophenols and o-aminophenolcarboxylic acids | Infineon Technologies AG (DE) | 2001-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010370-A1 | Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same | FOS, POF1B, FOSB | MEN1 3903/4885KMT2A 1691/4885NPC1 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.